Apr 24 FDA warns retailers against illegal sale of e-cigarettes to children By Matthew Perrone, Associated Press The Food and Drug Administration issued warnings to 40 retail and online stores as part of a month-long operation against illegal sales of Juul to children. Investigators targeted 7-Eleven locations, Shell gas stations and Cumberland Farms convenience stores as well… Continue reading
Apr 17 Marijuana-based drug gets positive review from FDA By Matthew Perrone, Associated Press The Food and Drug Administration posted its review Tuesday of the experimental medication ahead of a public meeting later this week. Continue reading
Feb 03 Physicians, ethicists urge Congress not to pass ‘right-to-try’ legislation By Ike Swetlitz, STAT Dozens of doctors, medical ethicists, and lawyers are warning Congress that legislation to allow Americans with life-threatening conditions access to unapproved, experimental drugs risks harming patients’ health. Continue reading
Jan 18 How a government shutdown could affect your health By Erin Mershon, Ike Swetlitz, STAT A government shutdown of the FDA, CDC and NIH will likely have widespread and long-lasting consequences for public health. Continue reading
Nov 18 FDA clears electronic earpiece to block opioid withdrawal symptoms By Max Blau, STAT A wearable device claiming to block the pain of opioid withdrawal has been cleared by the Food and Drug Administration under a new expedited review process. Continue reading
Nov 14 FDA approves sensor to track if patients take their medication By Associated Press Patients can track their dosage on their smartphone and allow their doctors or caregivers to access the information through a website. Continue reading
Oct 15 We may soon have our first $1 million drug. Who will pay for it? And how? By Meghana Keshavan, STAT As the first gene therapies approach the market, drug makers, insurers, and patients are debating complex questions about cost, value, and payment plans. Continue reading
Oct 05 WATCH LIVE: Senate committee weighs federal response to opioid crisis By Laura Santhanam The Senate Health, Education, Labor and Pensions Committee is scheduled to convene at 10 a.m. ET to discuss how well the federal government has responded to a mounting public health crisis over opioids. Continue reading
Jun 11 FDA wants to yank an opioid painkiller over concerns about abuse By Ed Silverman, STAT The Food and Drug Administration has asked Endo Pharmaceuticals to withdraw its Opana ER painkiller over concerns that the drug is too easily abused, the first time the agency has made such a move. Continue reading
Apr 21 FDA: Codeine cough syrup should not be given to kids By Kate Sheridan, STAT The FDA issued its strongest level of drug warnings Thursday concerning opioid pain-reliever use in children. Continue reading